Template:Antiarrhythmic agents
{{Navbox
| name = Antiarrhythmic agents
| title = Antiarrhythmic agents (C01B)
| state = {{{state|autocollapse}}}
|listclass = hlist
|group1 = Channel blockers
|list1 = {{Navbox|subgroup
| group1 = class I
(Na+ channel blockers)
| list1 = {{Navbox|subgroup
| group1 = class Ia (Phase 0→ and Phase 3→)
| list1 =
| group2 = class Ib (Phase 3←)
| list2 =
| group3 = class Ic (Phase 0→)
| list3 =
}}
| group3 = class III
(Phase 3→, K+ channel blockers)
| list3 =
- Amiodarone
- Bretylium
- Bunaftine
- Celivarone†
- Dofetilide
- Dronedarone
- E-4031†
- Ibutilide
- Nifekalant
- Sotalol
- Tedisamil
- Vernakalant
| group4 = class IV
(Phase 4→, Ca2+ channel blockers)
| list4 =
}}
|group2 = Receptor agonists
and antagonists
|list2 = {{Navbox|subgroup
| group2 = class II
(Phase 4→, β blockers)
| list2 =
- Nadolol
- Pindolol
- Propranolol
- cardioselective
- Acebutolol
- Atenolol
- Esmolol
- Landiolol
- Metoprolol
| group5 = A1 agonist
| list5 =
| group6 = M2
| list6 =
| group7 = α receptors
| list7 =
}}
| group8 = Ion transporters
| list8 = {{Navbox|subgroup
| group1 = Na+/ K+-ATPase
| list1 =
}}
| group9 =
| list9 = {{PharmNavFootnote}}
}}
{{collapsible option}}